These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 3112494

  • 21. Pertussis: current status of prevention and treatment.
    Bass JW.
    Pediatr Infect Dis; 1985; 4(6):614-9. PubMed ID: 3878499
    [No Abstract] [Full Text] [Related]

  • 22. [Reactions to adsorbed pertussis-diphtheria-tetanus vaccine].
    Zakharova MS, Vares AM, Vorob'eva AI, Ustinova VG.
    Pediatriia; 1971 Jan; 50(1):65-8. PubMed ID: 5573533
    [No Abstract] [Full Text] [Related]

  • 23. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
    Lee SY, Hwang HS, Kim JH, Kim HH, Lee HS, Chung EH, Park SE, Ma SH, Chang JK, Guitton F, Ortiz E, Kang JH.
    Vaccine; 2011 Feb 11; 29(8):1551-7. PubMed ID: 21215828
    [Abstract] [Full Text] [Related]

  • 24. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E, von Sonnenburg F, Sänger R, Abitbol V, Wolter JM, Schuerman LM.
    Vaccine; 2005 May 25; 23(28):3657-67. PubMed ID: 15882526
    [Abstract] [Full Text] [Related]

  • 25. [A study of the reactogenicity and immunogenicity of sorbed pertussis-diphtheria-tetanus vaccine with lowered doses of the compounds. I. Reactogenic properties of the drug].
    Tuĭmedova RA.
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Sep 25; 46(9):9-13. PubMed ID: 5357671
    [No Abstract] [Full Text] [Related]

  • 26. Reactogenicity of fluid compared with adsorbed diphtheria-pertussis-tetanus vaccine.
    Mathias RG.
    Can Med Assoc J; 1984 Jun 15; 130(12):1561-5. PubMed ID: 6610469
    [Abstract] [Full Text] [Related]

  • 27. [The immunologic effectiveness of vaccination against pertussis, diphtheria and tetanus upon alteration of the scheme of its administration].
    Sokhin AA, Kucheriavenko VS, Moshiazhvili IIa, Sapel'nikova LI, Arkad'eva VA.
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Jan 15; 50(1):132-3. PubMed ID: 4780100
    [No Abstract] [Full Text] [Related]

  • 28. [Reactogenic properties of a DTP vaccine with a reduced antigen dosage].
    Baeva EA, Selezneva TS, Kucherovskaia TV, Auzinia AV, Glinskaia EV.
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Oct 15; (10):47-50. PubMed ID: 2879401
    [Abstract] [Full Text] [Related]

  • 29. Vaccination and cot deaths in perspective.
    Roberts SC.
    Arch Dis Child; 1987 Jul 15; 62(7):754-9. PubMed ID: 3498443
    [Abstract] [Full Text] [Related]

  • 30. Half-dose immunization for diphtheria, tetanus, pertussis: response of preterm infants.
    Bernbaum J, Daft A, Samuelson J, Polin RA.
    Pediatrics; 1989 Apr 15; 83(4):471-6. PubMed ID: 2538797
    [Abstract] [Full Text] [Related]

  • 31. Repeated administration of a reduced-antigen-content diphtheria-tetanus-acellular pertussis and poliomyelitis vaccine (dTpa-IPV; Boostrix™ IPV).
    Knuf M, Vetter V, Celzo F, Ramakrishnan G, Van Der Meeren O, Jacquet JM.
    Hum Vaccin; 2010 Jul 15; 6(7):554-61. PubMed ID: 20448468
    [Abstract] [Full Text] [Related]

  • 32. Injections and poliomyelitis: what are the risks of vaccine associated paralysis?
    Wyatt HV.
    Dev Biol Stand; 1986 Jul 15; 65():123-6. PubMed ID: 3549394
    [Abstract] [Full Text] [Related]

  • 33. [Immunologic efficacy of immunizing 3--4-month old children with AKDS vaccine].
    Koval'skaia SI, Ozeretskovskiĭ NA, Braginskaia VP, Veĭsfeĭler OI.
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Oct 15; (10):48-51. PubMed ID: 4454827
    [No Abstract] [Full Text] [Related]

  • 34. Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures.
    N Y State J Med; 1982 Oct 15; 82(11):1563-9. PubMed ID: 6959004
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Erythema multiforme following diphtheria-pertussis-tetanus vaccination.
    Leung AK, Szabo TF.
    Kobe J Med Sci; 1987 Aug 15; 33(4):121-4. PubMed ID: 3501037
    [No Abstract] [Full Text] [Related]

  • 37. Primary immunization with diphtheria-tetanus toxoids vaccine and diphtheria-tetanus toxoids-pertussis vaccine adsorbed: comparison of schedules.
    Barkin RM, Samuelson JS, Gotlin LP, Barkin SZ.
    Pediatr Infect Dis; 1985 Aug 15; 4(2):168-71. PubMed ID: 3885180
    [Abstract] [Full Text] [Related]

  • 38. Pertussis immunization.
    Simon FA.
    Pediatrics; 1979 Sep 15; 64(3):387-8. PubMed ID: 481986
    [No Abstract] [Full Text] [Related]

  • 39. [Epidemiologic effectiveness of adsorbed scarlatina-diphtheria-pertussis-tetanus vaccine].
    Mitel'man SL, Akimova VV.
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Dec 15; 43(12):15-8. PubMed ID: 6004628
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.